2563 — Beijing Biostar Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.48bn
- HK$929.82m
- CNY33.36m
Annual cashflow statement for Beijing Biostar Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | CAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -161 | -190 | -144 | — |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 59.6 | 6.22 | -19.3 | — |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 11 | 22 | 50.6 | -152 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -79.4 | -151 | -103 | -152 |
| Capital Expenditures | -32.7 | -27.8 | -40.8 | -5.42 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -114 | 159 | 95 | 94.9 |
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -147 | 131 | 54.2 | 89.5 |
| Financing Cash Flow Items | 4.66 | -0.125 | -11.2 | -1.2 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 3.53 | -1.13 | 202 | -1.25 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -208 | -22 | 152 | -68.5 |